| Lucis Ladden, PA-C | |
|
19 Summerhaven Rd, Beavercreek, OH 45440-3624 | |
| (419) 348-5807 | |
| Not Available |
| Full Name | Lucis Ladden |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Location | 19 Summerhaven Rd, Beavercreek, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407524416 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 50.006983 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lucis Ladden, PA-C 1021 Kenilworth Ave Ste 2, Cleveland, OH 44113-4422 Ph: (419) 348-5807 | Lucis Ladden, PA-C 19 Summerhaven Rd, Beavercreek, OH 45440-3624 Ph: (419) 348-5807 |
News Archive
Avandia, a drug used as a treatment for type 2 diabetes was approved for use in 1999. However controversies have surrounded it since 2007 when a Cleveland Clinic cardiologist Steven E. Nissen published a study in the acclaimed New England Journal of Medicine that concluded that the drug significantly increased the risk for heart problems like heart attacks, heart failure and deaths.
Tufts University researchers have identified a gene-diet interaction that appears to influence body weight and have replicated their findings in three independent studies. Men and women carrying the CC genotype demonstrated higher body mass index (BMI) scores and a higher incidence of obesity, but only if they consumed a diet high in saturated fat. These associations were seen in the apolipoprotein A-II gene (APOA2) promoter.
Molecular Devices Corporation announced the launch of its QBT Fatty Acid Uptake Assay Kit, the first assay kit that addresses the need for a single-step, homogenous in vitro assay for fatty acid uptake for use in high- throughput screening and metabolic disease research.
Cell Therapeutics, Inc. (CTI) announced today that on December 24, 2009, CTI's Board of Directors (the "Board of Directors") approved and adopted a Shareholder Rights Plan (the "Rights Plan") in which one preferred stock purchase right will be distributed for each common share held as of the close of business on January 7, 2010. Initially, the rights are not exercisable, and are attached to and trade with, all of the shares of CTI's common stock outstanding as of, and issued subsequent to, the record date.
› Verified 6 days ago
Amanda Yun Anania, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3535 Pentagon Blvd Ste 330, Beavercreek, OH 45431 Phone: 937-757-9449 Fax: 937-702-4944 | |
Lindsey R Hammett, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 111 Harbert Dr, Beavercreek, OH 45440 Phone: 937-208-7575 Fax: 937-208-7590 | |
Emily Grace Trompak (o'neal), PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3535 Pentagon Blvd, Beavercreek, OH 45431 Phone: 937-702-4450 Fax: 937-702-4459 | |
Sarah Gould, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 2510 Commons Blvd Ste 210, Beavercreek, OH 45431 Phone: 937-429-0607 Fax: 937-429-0608 | |
Breanne Henderson, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 42 Woodcroft Trl, Beavercreek, OH 45430 Phone: 937-429-0682 | |
Kelly Bultman, Physician Assistant Medicare: Medicare Enrolled Practice Location: 2510 Commons Blvd Ste 210, Beavercreek, OH 45431 Phone: 513-833-4912 | |
Michelle A Ortman, P.A.-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 75 Sylvania Dr, Beavercreek, OH 45440 Phone: 937-320-5050 Fax: 937-320-5060 |